{
  "pmcid": "6704347",
  "sha256": "18f92f29706de5ea18ae402ad50db1cc5e901a4f7682f2d12480a288abe791c2",
  "timestamp_utc": "2025-11-10T00:02:54.515565+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.484729064039406,
    "reading_ease": 13.35103448275865,
    "word_count": 261
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Convection-Enhanced Delivery of Muscimol for Drug-Resistant Epilepsy"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "In this phase 1 randomised controlled trial, 3 adult patients with DRE were recruited from a single center."
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligibility criteria included adults with confirmed DRE."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants underwent convection-enhanced delivery (CED) of artificial CSF vehicle followed by muscimol into the seizure focus for 12 to 24 hours using a crossover design."
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was seizure frequency, assessed over the infusion period."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was conducted using a computer-generated sequence, and allocation was concealed."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not implemented."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Three patients were randomised, and all completed the study."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Three patients were randomised, and all completed the study."
      },
      "Result_Outcome": {
        "score": 1,
        "evidence": "Seizure frequency decreased in 1 of 3 patients during muscimol infusion but was unchanged during vehicle infusion."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 14,
    "max_score": 25
  }
}